Creative Biolabs-Immuno-oncology

Anti-GUCY2C (clone MS7J) SynExpress pL-R-P-X Modified CD8+ T cells (CAT#: ITS-1224-CR1076)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target GUCY2C (clone MS7J). We employs the Lentivirus (pL-RFP-PAX-XbaI) vector components and the SynExpress system of the lncRNA Base Editing/Delayed feedback for a robust and sustained response against cancers.
Host
Human
Target
GUCY2C
Clone
MS7J
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
RFP
Promoter
pL
Effector Gene
PAX
Insertion Sites
XbaI
Gene Modification
Base Editing
Modification Domain
lncRNA
Carrier Type
Lentivirus
Transformation Accuracy
0.99
Cell Culture
3D Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.